Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression

Different functioning of prefrontal cortex predicts treatment response after a selective serotonin reuptake inhibitor treatment in patients with major depression

(2017) Koji Masuda et al.   JOURNAL OF AFFECTIVE DISORDERS

Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance

(2017) Wen-Jun Su et al.   Journal of Neuroinflammation

Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet–Induced Obese Rats

(2017) Thomas B. Estridge et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Metabolic Effects of Antidepressant Treatment

(2017) Ozlem Olguner Eker et al.   Noropsikiyatri Arsivi-Archives of Neuropsychiatry

Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF–TrkB Signaling

(2017) Kun Li et al.   Neuroscience Bulletin

Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression

(2016) Ren-Hong Du et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder

(2016) Katrine Kveli Fjukstad et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Metformin increases hepatic leptin receptor and decreases steatosis in mice

(2016) Xuemei Tang et al.   JOURNAL OF ENDOCRINOLOGY

Association between major depression and cardiovascular risk: the role of antidepressant medication

(2016) Linn K. Kuehl et al.   PSYCHOPHARMACOLOGY

Fluoxetine suppresses AMP-activated protein kinase signaling pathway to promote hepatic lipid accumulation in primary mouse hepatocytes

(2014) Jing Xiong et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis inob/obmice

(2013) Fatiha Nassir et al.   JOURNAL OF LIPID RESEARCH

Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression

(2013) Esmaeil Shahsavand Ananloo et al.   DARU-Journal of Pharmaceutical Sciences

Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation

(2012) Da Xiao et al.   BIOCHEMICAL PHARMACOLOGY

Fluoxetine Induces Hepatic Lipid Accumulation Via Both Promotion of the SREBP1c-Related Lipogenesis and Reduction of Lipolysis in Primary Mouse Hepatocytes

(2012) Xue-Min Feng et al.   CNS Neuroscience & Therapeutics

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Role of endoplasmic reticulum neutral lipid hydrolases

(2011) Ariel D. Quiroga et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

(2010) Amy H. Farabaugh et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Incidence of major depressive episode correlates with elevation of substate region of residence

(2010) Kristen DelMastro et al.   JOURNAL OF AFFECTIVE DISORDERS

Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes

(2009) Kerry W.S. Ko et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Paroxetine-induced increase in LDL cholesterol levels

(2008) JM Le Melledo et al.   JOURNAL OF PSYCHOPHARMACOLOGY